PDB37 IS INSULIN GLARGINE A COST-EFFECTIVE OPTION FOR TREATMENT OF PATIENTS NAÏVE TO INSULIN TREATMENT WITH TYPE 2, BASELINE HBA1C ABOVE 8% AND AGE BELOW 65YEARS IN COMPARISON TO NPH AND PREMIX IN POLAND?

✍ Scribed by P McEwan; A Woehl; P Kawalec; J Lis; J Gierczynski; J Walczak

• Book ID: 119597535
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 99 KB
• Volume: 11
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)66685-5